Correlation Between Cyclacel Pharmaceuticals and BioCryst Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Cyclacel Pharmaceuticals and BioCryst Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Cyclacel Pharmaceuticals and BioCryst Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Cyclacel Pharmaceuticals and BioCryst Pharmaceuticals, you can compare the effects of market volatilities on Cyclacel Pharmaceuticals and BioCryst Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Cyclacel Pharmaceuticals with a short position of BioCryst Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Cyclacel Pharmaceuticals and BioCryst Pharmaceuticals.
Diversification Opportunities for Cyclacel Pharmaceuticals and BioCryst Pharmaceuticals
0.38 | Correlation Coefficient |
Weak diversification
The 3 months correlation between Cyclacel and BioCryst is 0.38. Overlapping area represents the amount of risk that can be diversified away by holding Cyclacel Pharmaceuticals and BioCryst Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on BioCryst Pharmaceuticals and Cyclacel Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Cyclacel Pharmaceuticals are associated (or correlated) with BioCryst Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of BioCryst Pharmaceuticals has no effect on the direction of Cyclacel Pharmaceuticals i.e., Cyclacel Pharmaceuticals and BioCryst Pharmaceuticals go up and down completely randomly.
Pair Corralation between Cyclacel Pharmaceuticals and BioCryst Pharmaceuticals
Given the investment horizon of 90 days Cyclacel Pharmaceuticals is expected to under-perform the BioCryst Pharmaceuticals. In addition to that, Cyclacel Pharmaceuticals is 2.02 times more volatile than BioCryst Pharmaceuticals. It trades about -0.08 of its total potential returns per unit of risk. BioCryst Pharmaceuticals is currently generating about 0.04 per unit of volatility. If you would invest 588.00 in BioCryst Pharmaceuticals on August 26, 2024 and sell it today you would earn a total of 172.00 from holding BioCryst Pharmaceuticals or generate 29.25% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Cyclacel Pharmaceuticals vs. BioCryst Pharmaceuticals
Performance |
| Timeline |
| Cyclacel Pharmaceuticals |
| BioCryst Pharmaceuticals |
Cyclacel Pharmaceuticals and BioCryst Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Cyclacel Pharmaceuticals and BioCryst Pharmaceuticals
The main advantage of trading using opposite Cyclacel Pharmaceuticals and BioCryst Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Cyclacel Pharmaceuticals position performs unexpectedly, BioCryst Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in BioCryst Pharmaceuticals will offset losses from the drop in BioCryst Pharmaceuticals' long position.| Cyclacel Pharmaceuticals vs. Eliem Therapeutics | Cyclacel Pharmaceuticals vs. Ikena Oncology | Cyclacel Pharmaceuticals vs. Ovid Therapeutics | Cyclacel Pharmaceuticals vs. Connect Biopharma Holdings |
| BioCryst Pharmaceuticals vs. TG Therapeutics | BioCryst Pharmaceuticals vs. Axsome Therapeutics | BioCryst Pharmaceuticals vs. Seres Therapeutics | BioCryst Pharmaceuticals vs. Madrigal Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Top Crypto Exchanges module to search and analyze digital assets across top global cryptocurrency exchanges.
Other Complementary Tools
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device |